﻿<?xml version="1.0" encoding="utf-8"?>
<Return xmlns="http://www.irs.gov/efile" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.irs.gov/efile" returnVersion="2018v3.1">
  <ReturnHeader binaryAttachmentCnt="0">
    <ReturnTs>2019-11-06T11:44:13-06:00</ReturnTs>
    <TaxPeriodEndDt>2018-12-31</TaxPeriodEndDt>
    <PreparerFirmGrp>
      <PreparerFirmEIN>271728945</PreparerFirmEIN>
      <PreparerFirmName>
        <BusinessNameLine1Txt>PKF O'CONNOR DAVIES LLP</BusinessNameLine1Txt>
      </PreparerFirmName>
      <PreparerUSAddress>
        <AddressLine1Txt>665 FIFTH AVENUE</AddressLine1Txt>
        <CityNm>NEW YORK</CityNm>
        <StateAbbreviationCd>NY</StateAbbreviationCd>
        <ZIPCd>10022</ZIPCd>
      </PreparerUSAddress>
    </PreparerFirmGrp>
    <ReturnTypeCd>990</ReturnTypeCd>
    <TaxPeriodBeginDt>2018-01-01</TaxPeriodBeginDt>
    <Filer>
      <EIN>133859563</EIN>
      <BusinessName>
        <BusinessNameLine1Txt>THE ZACHARY &amp; ELIZABETH M FISHER CENTER</BusinessNameLine1Txt>
        <BusinessNameLine2Txt>FOR ALZHEIMER'S RESEARCH FOUNDATION</BusinessNameLine2Txt>
      </BusinessName>
      <BusinessNameControlTxt>ZACH</BusinessNameControlTxt>
      <PhoneNum>2129151321</PhoneNum>
      <USAddress>
        <AddressLine1Txt>110 EAST 42ND STREET 16TH FLOOR</AddressLine1Txt>
        <CityNm>NEW YORK</CityNm>
        <StateAbbreviationCd>NY</StateAbbreviationCd>
        <ZIPCd>10017</ZIPCd>
      </USAddress>
    </Filer>
    <BusinessOfficerGrp>
      <PersonNm>KENT KAROSEN</PersonNm>
      <PersonTitleTxt>CHAIRMAN &amp; TREASURER</PersonTitleTxt>
      <PhoneNum>2129151321</PhoneNum>
      <SignatureDt>2019-11-06</SignatureDt>
      <DiscussWithPaidPreparerInd>1</DiscussWithPaidPreparerInd>
    </BusinessOfficerGrp>
    <PreparerPersonGrp>
      <PreparerPersonNm>GARRETT M HIGGINS</PreparerPersonNm>
      <PTIN>P00543209</PTIN>
      <PhoneNum>2122862600</PhoneNum>
      <PreparationDt>2019-11-04</PreparationDt>
    </PreparerPersonGrp>
    <FilingSecurityInformation>
      <IPAddress>
        <IPv4AddressTxt>4.15.211.182</IPv4AddressTxt>
      </IPAddress>
      <IPDt>2019-11-06</IPDt>
      <IPTm>10:52:26</IPTm>
      <IPTimezoneCd>ES</IPTimezoneCd>
      <FilingLicenseTypeCd>P</FilingLicenseTypeCd>
      <AtSubmissionCreationDeviceId>DA39A3EE5E6B4B0D3255BFEF95601890AFD80709</AtSubmissionCreationDeviceId>
      <AtSubmissionFilingDeviceId>B29914CEB47F2C50F9800CDE5B5AE22990D509AB</AtSubmissionFilingDeviceId>
    </FilingSecurityInformation>
    <TaxYr>2018</TaxYr>
    <BuildTS>2020-03-31 21:24:44Z</BuildTS>
  </ReturnHeader>
  <ReturnData documentCnt="10">
    <IRS990 documentId="RetDoc1038000001" referenceDocumentId="RetDoc1044400001">
      <DoingBusinessAsName>
        <BusinessNameLine1Txt>ALZHEIMER'S RESEARCH FDNFISHER CTR</BusinessNameLine1Txt>
      </DoingBusinessAsName>
      <PrincipalOfficerNm>BARRY SLOANE</PrincipalOfficerNm>
      <USAddress>
        <AddressLine1Txt>110 EAST 42ND STREET 16TH FLOOR</AddressLine1Txt>
        <CityNm>NEW YORK</CityNm>
        <StateAbbreviationCd>NY</StateAbbreviationCd>
        <ZIPCd>10017</ZIPCd>
      </USAddress>
      <GrossReceiptsAmt>15018624</GrossReceiptsAmt>
      <GroupReturnForAffiliatesInd>0</GroupReturnForAffiliatesInd>
      <Organization501c3Ind>X</Organization501c3Ind>
      <WebsiteAddressTxt>WWW.ALZINFO.ORG</WebsiteAddressTxt>
      <TypeOfOrganizationCorpInd>X</TypeOfOrganizationCorpInd>
      <FormationYr>1995</FormationYr>
      <LegalDomicileStateCd>NY</LegalDomicileStateCd>
      <ActivityOrMissionDesc>SEE SCHEDULE O.</ActivityOrMissionDesc>
      <VotingMembersGoverningBodyCnt>15</VotingMembersGoverningBodyCnt>
      <VotingMembersIndependentCnt>14</VotingMembersIndependentCnt>
      <TotalEmployeeCnt>9</TotalEmployeeCnt>
      <TotalVolunteersCnt>56</TotalVolunteersCnt>
      <TotalGrossUBIAmt>0</TotalGrossUBIAmt>
      <NetUnrelatedBusTxblIncmAmt>3503</NetUnrelatedBusTxblIncmAmt>
      <PYContributionsGrantsAmt>6064311</PYContributionsGrantsAmt>
      <CYContributionsGrantsAmt>5365421</CYContributionsGrantsAmt>
      <PYProgramServiceRevenueAmt>0</PYProgramServiceRevenueAmt>
      <CYProgramServiceRevenueAmt>0</CYProgramServiceRevenueAmt>
      <PYInvestmentIncomeAmt>1739866</PYInvestmentIncomeAmt>
      <CYInvestmentIncomeAmt>-136890</CYInvestmentIncomeAmt>
      <PYOtherRevenueAmt>1790</PYOtherRevenueAmt>
      <CYOtherRevenueAmt>670</CYOtherRevenueAmt>
      <PYTotalRevenueAmt>7805967</PYTotalRevenueAmt>
      <CYTotalRevenueAmt>5229201</CYTotalRevenueAmt>
      <PYGrantsAndSimilarPaidAmt>3298278</PYGrantsAndSimilarPaidAmt>
      <CYGrantsAndSimilarPaidAmt>2820707</CYGrantsAndSimilarPaidAmt>
      <PYBenefitsPaidToMembersAmt>0</PYBenefitsPaidToMembersAmt>
      <CYBenefitsPaidToMembersAmt>0</CYBenefitsPaidToMembersAmt>
      <PYSalariesCompEmpBnftPaidAmt>896563</PYSalariesCompEmpBnftPaidAmt>
      <CYSalariesCompEmpBnftPaidAmt>1096670</CYSalariesCompEmpBnftPaidAmt>
      <PYTotalProfFndrsngExpnsAmt>0</PYTotalProfFndrsngExpnsAmt>
      <CYTotalProfFndrsngExpnsAmt>0</CYTotalProfFndrsngExpnsAmt>
      <CYTotalFundraisingExpenseAmt>274062</CYTotalFundraisingExpenseAmt>
      <PYOtherExpensesAmt>433612</PYOtherExpensesAmt>
      <CYOtherExpensesAmt>519254</CYOtherExpensesAmt>
      <PYTotalExpensesAmt>4628453</PYTotalExpensesAmt>
      <CYTotalExpensesAmt>4436631</CYTotalExpensesAmt>
      <PYRevenuesLessExpensesAmt>3177514</PYRevenuesLessExpensesAmt>
      <CYRevenuesLessExpensesAmt>792570</CYRevenuesLessExpensesAmt>
      <TotalAssetsBOYAmt>27353916</TotalAssetsBOYAmt>
      <TotalAssetsEOYAmt>26210287</TotalAssetsEOYAmt>
      <TotalLiabilitiesBOYAmt>4114782</TotalLiabilitiesBOYAmt>
      <TotalLiabilitiesEOYAmt>3544564</TotalLiabilitiesEOYAmt>
      <NetAssetsOrFundBalancesBOYAmt>23239134</NetAssetsOrFundBalancesBOYAmt>
      <NetAssetsOrFundBalancesEOYAmt>22665723</NetAssetsOrFundBalancesEOYAmt>
      <InfoInScheduleOPartIIIInd>X</InfoInScheduleOPartIIIInd>
      <MissionDesc>SEE SCHEDULE O.THE ZACHARY AND ELIZABETH M. FISHER ALZHEIMER'S RESEARCH FOUNDATION IS DEDICATED TO ATTACKING THE SCOURGE OF ALZHEIMER'S DISEASE THROUGH A 3-PRONGED ASSAULT FOCUSED ON UNDERSTANDING THE CAUSE OF ALZHEIMER'S DISEASE; IMPROVING THE CARE OF PEOPLE LIVING WITH THE DISEASE TO ENHANCE THEIR QUALITY OF LIFE AND THAT OF THEIR CAREGIVERS AND FAMILIES; AND FINDING A CURE FOR THIS DEVASTATING DISEASE.</MissionDesc>
      <SignificantNewProgramSrvcInd>0</SignificantNewProgramSrvcInd>
      <SignificantChangeInd>0</SignificantChangeInd>
      <ExpenseAmt>2695707</ExpenseAmt>
      <GrantAmt>2695707</GrantAmt>
      <Desc>A GRANT WAS MADE TO THE FISHER CENTER FOR ALZHEIMER'S RESEARCH AT THE ROCKEFELLER UNIVERSITY (RU) TO RESEARCH THE CAUSES OF ALZHEIMER'S DISEASE (AD) AND IDENTIFY POTENTIAL NEW PHARMACOLOGICAL TREATMENT OPTIONS. THE LABORATORY IS UNDER THE DIRECTION OF NOBEL LAUREATE DR. PAUL GREENGARD. A GRANT WAS MADE TO RU TO ESTABLISH THE PAUL GREENGARD PROFESSORSHIP (ESTABLISHED IN PERPETUITY) TO RECOGNIZE DR. PAUL GREENGARD. THIS WILL ENSURE A CONTINUED COMMITMENT TO THE OUTSTANDING RESEARCH BY THE FISHER CENTER FOR ALZHEIMER'S RESEARCH LABORATORY. THE PROFESSORSHIP WILL BE HELD BY AN OUTSTANDING SCIENTIST AT RU WORKING IN THE FIELD OF AD. THE $5 MILLION GRANT WILL BE PAID TO RU OVER SEVEN YEARS.1) SPECIFIC TYPES OF NERVE CELLS (NEURONS) ARE MORE SUSCEPTIBLE (VULNERABLE) TO THE AD PATHOLOGY, BEING AFFECTED AND DISAPPEARING SOONER THAN OTHER NEURONS (RESISTANT). FISHER SCIENTISTS ARE USING A UNIQUE SET OF TECHNOLOGIES TO BETTER UNDERSTAND UNDERLYING CAUSES OF THIS PROCESS AND HELP DESIGN ENTIRELY NEW THERAPEUTIC STRATEGIES. THEY ARE CURRENTLY CHARACTERIZING NEW GENES THAT THEY HAVE LINKED TO VULNERABILITY. 2) IN OTHER RESEARCH, THE SCIENTISTS ACCELERATED THE BREAKDOWN OF THE TOXIC BETA-AMYLOID COMPONENT BY TARGETING A CELLULAR PROCESS CALLED AUTOPHAGY, A PROCESS RESPONSIBLE FOR REMOVING DEBRIS FROM THE CELLS. THE SCIENTISTS IDENTIFIED A NOVEL SIGNALING NETWORK WITHIN NEURONS THAT REGULATES BETA-AMYLOID DEGRADATION. 3) FISHER SCIENTISTS FURTHER DEVELOP THERAPEUTIC APPROACHES AND BUILD A NOVEL PLATFORM FOR DRUG DISCOVERY APPLICATIONS. THEY CONTINUED CHARACTERIZING AND OPTIMIZING CHEMICALLY ACTIVE MOLECULES. ONE MOLECULE IDENTIFIED MIGHT ACT AS A MUTATION (A673T) THAT PROTECT PEOPLE FROM DEVELOPING AD. 4) LASTLY, THE FISHER SCIENTISTS ARE STUDYING A TYPE OF CELL CALLED MICROGLIA THAT CONTRIBUTES TO AD PATHOGENESIS. THE FISHER SCIENTISTS HAVE SHOWN THAT THEY CAN MODULATE AD-LIKE HALLMARKS IN VIVO BY ACTING ON MICROGLIA.</Desc>
      <ProgSrvcAccomActy2Grp>
        <ExpenseAmt>989177</ExpenseAmt>
        <Desc>THE FISHER CENTER ALZHEIMER'S INFORMATION PROGRAM PROMOTES PUBLIC AWARENESS AND EDUCATION ABOUT ALZHEIMER'S AND INFORMATION ON CAREGIVING. THE PROGRAM USES BOTH ONLINE AND TRADITIONAL MEDIA CONDUITS TO KEEP THE PUBLIC INFORMED WITH COMPREHENSIVE INFORMATION ABOUT ALZHEIMER'S, RECENT RESEARCH STUDIES, TREATMENTS AND DISEASE MANAGEMENT APPROACHES THROUGH ITS PUBLICATION, PRESERVING YOUR MEMORY MAGAZINE (CIRCULATION: 49,944; PUBLISHED THREE TIMES A YEAR, WITH AN ESTIMATED READERSHIP OF ALMOST ONE MILLION ANNUALLY), WHICH IS DISTRIBUTED TO HEALTH CARE AND COMMUNITY ORGANIZATIONS NATIONWIDE. THE FISHER CENTER FOR ALZHEIMER'S RESEARCH FOUNDATION HAS A WEBSITE (ALZINFO.ORG) AND DISTRIBUTES BIWEEKLY E-NEWSLETTERS OF EXPERT-REVIEWED ALZHEIMER'S NEWS AND RESEARCH TO OVER 27,000 SUBSCRIBERS. THE WEBSITE IS UPDATED REGULARLY WITH FRESH CONTENT ON ALZHEIMER'S, CAREGIVING AND RESEARCH. IN 2018, THE WEBSITE HAD 540,000 UNIQUE VISITORS. FURTHERMORE, OUR SOCIAL PLATFORMS HAVE A COMBINED REACH OF OVER 45,000 FOLLOWERS.THE FOUNDATION ALSO HAS A BOOK, WHY CAN'T GRANDMA REMEMBER MY NAME, WRITTEN BY FOUNDATION PRESIDENT KENT L. KAROSEN AND CO-AUTHORED BY CHANA STIEFEL. THE BOOK EXPLAINS ALZHEIMER'S DISEASE BY INTEGRATING ARTWORK CREATED BY CHILDREN JUXTAPOSED WITH ART CREATED BY ALZHEIMER'S PATIENTS, DEMONSTRATING THE POWER OF ART THERAPY FOR ALL AGES AND ALLOWS PARENTS AND FAMILY TO SHARE WITH A YOUNGER AUDIENCE WHAT IS HAPPENING TO THEIR LOVED ONES.</Desc>
      </ProgSrvcAccomActy2Grp>
      <ProgSrvcAccomActy3Grp>
        <ExpenseAmt>125000</ExpenseAmt>
        <GrantAmt>125000</GrantAmt>
        <Desc>IN 2018, A GRANT WAS MADE TO THE FISHER ALZHEIMER'S DISEASE PROGRAM AT THE NYUSOM FOR THE FISHER ALZHEIMER'S RESEARCH FOUNDATION WHERE DRS. REISBERG AND KENOWSKY COMPLETED SIGNIFICANT RESEARCH ON THE HEALTH OUTCOMES OF OUR COMPREHENSIVE, INDIVIDUALIZED, PERSON-CENTERED MANAGEMENT PROGRAM (CI-PCM) FOR PERSONS WITH ADVANCED ALZHEIMER'S DISEASE (AD). DR. REISBERG CHAIRED A FEATURED RESEARCH SESSION AT THE ALZHEIMER'S ASSOCIATION INTERNATIONAL CONFERENCE IN CHICAGO ENTITLED, "ECOPSYCHOSOCIAL TREATMENTS OF DEMENTIA". HE PRESENTED FINDINGS THAT PARTICIPANTS WHO RECEIVED THE MANAGEMENT PROGRAM FOR 28-WEEKS, SIGNIFICANTLY IMPROVED IN TERMS OF THEIR MOOD AND BEHAVIOR. THEY EXPERIENCED LESS AGITATION, COMBATIVE BEHAVIOR AND NIGHTTIME WAKEFULNESS, WHILE REQUIRING LESS ANTIANXIETY MEDICATION. THE SERIOUS SIDE EFFECTS OF THESE ANTIANXIETY MEDICATIONS MAY INCLUDE: INCREASED RISK OF FALLS, DELIRIUM, AND DEATH. THE COMPARISON GROUP EXPERIENCED MORE BEHAVIORAL SYMPTOMS AND TOOK MORE ANTIANXIETY MEDICATION. THESE FINDINGS HIGHLIGHT THE IMPORTANCE OF USING PROPER MANAGEMENT TECHNIQUES TO TREAT THESE SYMPTOMS. THE CI-PCM PROGRAM DECREASED THE RISK OF HOSPITALIZATION BY 67%, AND EMERGENCY ROOM VISITS BY 50%, IN PERSONS WITH ADVANCED ALZHEIMER'S. THESE FINDINGS WERE PUBLISHED IN ALZHEIMER'S AND DEMENTIA. ADDITIONALLY, IT WAS FOUND IN THE RESEARCH ON NORMAL PEOPLE WITHOUT MEMORY COMPLAINTS THAT COGNITIVE DECLINE COULD BE DETECTED ON PSYCHOMETRIC TESTS IN THOSE PERSONS WHO SUBSEQUENTLY PROGRESS TO SUBJECTIVE COGNITIVE DECLINE, IN THE COURSE LEADING TO THE EVENTUAL DEMENTIA OF AD. DR. REISBERG NAMED THIS NEW STAGE, "PSYCHOMETRIC COGNITIVE DECLINE AND PRESENTED THESE FINDINGS AT THE AMERICAN COLLEGE OF NEUROPSYCHOPHARMACOLOGY. DATA ENTRY AND ANALYSIS WAS COMPLETED ON RESEARCH PROJECT ON THE 2-YEAR OUTCOMES AND MARKERS OF DECLINE IN NORMAL OLDER PERSONS WITH SUBJECTIVE COGNITIVE DECLINE. IN SUMMARY, IN THE PAST YEAR THE DOCTORS DEMONSTRATED IMPORTANT ADDITIONAL POSITIVE EFFECTS AND ADVANTAGES OF THEIR COMPREHENSIVE MANAGEMENT PROGRAM, AND DISCOVERED A NEW STAGE LEADING TO EVENTUAL AD.</Desc>
      </ProgSrvcAccomActy3Grp>
      <TotalProgramServiceExpensesAmt>3809884</TotalProgramServiceExpensesAmt>
      <DescribedInSection501c3Ind referenceDocumentId="RetDoc1039100001">1</DescribedInSection501c3Ind>
      <ScheduleBRequiredInd referenceDocumentId="RetDoc1234500001">1</ScheduleBRequiredInd>
      <PoliticalCampaignActyInd>0</PoliticalCampaignActyInd>
      <LobbyingActivitiesInd>0</LobbyingActivitiesInd>
      <SubjectToProxyTaxInd>0</SubjectToProxyTaxInd>
      <DonorAdvisedFundInd referenceDocumentId="RetDoc1040000001">0</DonorAdvisedFundInd>
      <ConservationEasementsInd referenceDocumentId="RetDoc1040000001">0</ConservationEasementsInd>
      <CollectionsOfArtInd referenceDocumentId="RetDoc1040000001">0</CollectionsOfArtInd>
      <CreditCounselingInd referenceDocumentId="RetDoc1040000001">0</CreditCounselingInd>
      <TempOrPermanentEndowmentsInd referenceDocumentId="RetDoc1040000001">0</TempOrPermanentEndowmentsInd>
      <ReportLandBuildingEquipmentInd referenceDocumentId="RetDoc1040000001">1</ReportLandBuildingEquipmentInd>
      <ReportInvestmentsOtherSecInd referenceDocumentId="RetDoc1040000001">0</ReportInvestmentsOtherSecInd>
      <ReportProgramRelatedInvstInd referenceDocumentId="RetDoc1040000001">0</ReportProgramRelatedInvstInd>
      <ReportOtherAssetsInd referenceDocumentId="RetDoc1040000001">0</ReportOtherAssetsInd>
      <ReportOtherLiabilitiesInd referenceDocumentId="RetDoc1040000001">0</ReportOtherLiabilitiesInd>
      <IncludeFIN48FootnoteInd referenceDocumentId="RetDoc1040000001">1</IncludeFIN48FootnoteInd>
      <IndependentAuditFinclStmtInd referenceDocumentId="RetDoc1040000001">1</IndependentAuditFinclStmtInd>
      <ConsolidatedAuditFinclStmtInd referenceDocumentId="RetDoc1040000001">0</ConsolidatedAuditFinclStmtInd>
      <SchoolOperatingInd>0</SchoolOperatingInd>
      <ForeignOfficeInd>0</ForeignOfficeInd>
      <ForeignActivitiesInd referenceDocumentId="RetDoc1040500001">1</ForeignActivitiesInd>
      <MoreThan5000KToOrgInd referenceDocumentId="RetDoc1040500001">1</MoreThan5000KToOrgInd>
      <MoreThan5000KToIndividualsInd referenceDocumentId="RetDoc1040500001">0</MoreThan5000KToIndividualsInd>
      <ProfessionalFundraisingInd>0</ProfessionalFundraisingInd>
      <FundraisingActivitiesInd>0</FundraisingActivitiesInd>
      <GamingActivitiesInd>0</GamingActivitiesInd>
      <OperateHospitalInd>0</OperateHospitalInd>
      <GrantsToOrganizationsInd referenceDocumentId="RetDoc1041900001">1</GrantsToOrganizationsInd>
      <GrantsToIndividualsInd referenceDocumentId="RetDoc1041900001">0</GrantsToIndividualsInd>
      <ScheduleJRequiredInd referenceDocumentId="RetDoc1042400001">1</ScheduleJRequiredInd>
      <TaxExemptBondsInd>0</TaxExemptBondsInd>
      <EngagedInExcessBenefitTransInd referenceDocumentId="RetDoc1042800001">0</EngagedInExcessBenefitTransInd>
      <PYExcessBenefitTransInd referenceDocumentId="RetDoc1042800001">0</PYExcessBenefitTransInd>
      <LoanOutstandingInd referenceDocumentId="RetDoc1042800001">0</LoanOutstandingInd>
      <GrantToRelatedPersonInd referenceDocumentId="RetDoc1042800001">0</GrantToRelatedPersonInd>
      <BusinessRlnWithOrgMemInd referenceDocumentId="RetDoc1042800001">0</BusinessRlnWithOrgMemInd>
      <BusinessRlnWithFamMemInd referenceDocumentId="RetDoc1042800001">0</BusinessRlnWithFamMemInd>
      <BusinessRlnWithOfficerEntInd referenceDocumentId="RetDoc1042800001">1</BusinessRlnWithOfficerEntInd>
      <DeductibleNonCashContriInd referenceDocumentId="RetDoc1042900001">1</DeductibleNonCashContriInd>
      <DeductibleArtContributionInd referenceDocumentId="RetDoc1042900001">0</DeductibleArtContributionInd>
      <TerminateOperationsInd>0</TerminateOperationsInd>
      <PartialLiquidationInd>0</PartialLiquidationInd>
      <DisregardedEntityInd>0</DisregardedEntityInd>
      <RelatedEntityInd>0</RelatedEntityInd>
      <RelatedOrganizationCtrlEntInd>0</RelatedOrganizationCtrlEntInd>
      <TrnsfrExmptNonChrtblRltdOrgInd>0</TrnsfrExmptNonChrtblRltdOrgInd>
      <ActivitiesConductedPrtshpInd>0</ActivitiesConductedPrtshpInd>
      <ScheduleORequiredInd>1</ScheduleORequiredInd>
      <IRPDocumentCnt>7</IRPDocumentCnt>
      <IRPDocumentW2GCnt>0</IRPDocumentW2GCnt>
      <EmployeeCnt>9</EmployeeCnt>
      <EmploymentTaxReturnsFiledInd>1</EmploymentTaxReturnsFiledInd>
      <UnrelatedBusIncmOverLimitInd>1</UnrelatedBusIncmOverLimitInd>
      <Form990TFiledInd>1</Form990TFiledInd>
      <ForeignFinancialAccountInd>0</ForeignFinancialAccountInd>
      <ProhibitedTaxShelterTransInd>0</ProhibitedTaxShelterTransInd>
      <TaxablePartyNotificationInd>0</TaxablePartyNotificationInd>
      <NondeductibleContributionsInd>0</NondeductibleContributionsInd>
      <QuidProQuoContributionsInd>0</QuidProQuoContributionsInd>
      <Form8282PropertyDisposedOfInd>0</Form8282PropertyDisposedOfInd>
      <RcvFndsToPayPrsnlBnftCntrctInd>0</RcvFndsToPayPrsnlBnftCntrctInd>
      <PayPremiumsPrsnlBnftCntrctInd>0</PayPremiumsPrsnlBnftCntrctInd>
      <IndoorTanningServicesInd>0</IndoorTanningServicesInd>
      <SubjToTaxRmnrtnExPrchtPymtInd>0</SubjToTaxRmnrtnExPrchtPymtInd>
      <SubjectToExcsTaxNetInvstIncInd>0</SubjectToExcsTaxNetInvstIncInd>
      <InfoInScheduleOPartVIInd>X</InfoInScheduleOPartVIInd>
      <GoverningBodyVotingMembersCnt>15</GoverningBodyVotingMembersCnt>
      <IndependentVotingMemberCnt>14</IndependentVotingMemberCnt>
      <FamilyOrBusinessRlnInd>1</FamilyOrBusinessRlnInd>
      <DelegationOfMgmtDutiesInd>0</DelegationOfMgmtDutiesInd>
      <ChangeToOrgDocumentsInd>0</ChangeToOrgDocumentsInd>
      <MaterialDiversionOrMisuseInd>0</MaterialDiversionOrMisuseInd>
      <MembersOrStockholdersInd>0</MembersOrStockholdersInd>
      <ElectionOfBoardMembersInd>0</ElectionOfBoardMembersInd>
      <DecisionsSubjectToApprovaInd>0</DecisionsSubjectToApprovaInd>
      <MinutesOfGoverningBodyInd>1</MinutesOfGoverningBodyInd>
      <MinutesOfCommitteesInd>1</MinutesOfCommitteesInd>
      <OfficerMailingAddressInd>0</OfficerMailingAddressInd>
      <LocalChaptersInd>0</LocalChaptersInd>
      <Form990ProvidedToGvrnBodyInd>1</Form990ProvidedToGvrnBodyInd>
      <ConflictOfInterestPolicyInd>1</ConflictOfInterestPolicyInd>
      <AnnualDisclosureCoveredPrsnInd>1</AnnualDisclosureCoveredPrsnInd>
      <RegularMonitoringEnfrcInd>1</RegularMonitoringEnfrcInd>
      <WhistleblowerPolicyInd>1</WhistleblowerPolicyInd>
      <DocumentRetentionPolicyInd>1</DocumentRetentionPolicyInd>
      <CompensationProcessCEOInd>1</CompensationProcessCEOInd>
      <CompensationProcessOtherInd>0</CompensationProcessOtherInd>
      <InvestmentInJointVentureInd>0</InvestmentInJointVentureInd>
      <StatesWhereCopyOfReturnIsFldCd>AZ</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>CT</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>UT</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>IL</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>MI</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>MO</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>MT</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>NJ</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>NY</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>NC</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>OH</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>PA</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>RI</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>TX</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>VA</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>WA</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>WI</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>CA</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>MD</StatesWhereCopyOfReturnIsFldCd>
      <OwnWebsiteInd>X</OwnWebsiteInd>
      <OtherWebsiteInd>X</OtherWebsiteInd>
      <UponRequestInd>X</UponRequestInd>
      <BooksInCareOfDetail>
        <BusinessName>
          <BusinessNameLine1Txt>LUCRETIA HOLDEN</BusinessNameLine1Txt>
        </BusinessName>
        <PhoneNum>2129151324</PhoneNum>
        <USAddress>
          <AddressLine1Txt>110 EAST 42ND STREET FL 16</AddressLine1Txt>
          <CityNm>NEW YORK</CityNm>
          <StateAbbreviationCd>NY</StateAbbreviationCd>
          <ZIPCd>10017</ZIPCd>
        </USAddress>
      </BooksInCareOfDetail>
      <Form990PartVIISectionAGrp>
        <PersonNm>BARRY SLOANE</PersonNm>
        <TitleTxt>CHAIRMAN/TREASURER</TitleTxt>
        <AverageHoursPerWeekRt>5.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>HOWARD LUTNICK</PersonNm>
        <TitleTxt>CO-VICE CHAIR</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>MARTIN EDELMAN</PersonNm>
        <TitleTxt>CO-VICE CHAIR</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>KENT KAROSEN</PersonNm>
        <TitleTxt>PRESIDENT/CEO (THRU NOV. 2018)</TitleTxt>
        <AverageHoursPerWeekRt>30.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>406250</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>MURRAY RUBIN</PersonNm>
        <TitleTxt>SECRETARY</TitleTxt>
        <AverageHoursPerWeekRt>2.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>DR MANNY ALVAREZ</PersonNm>
        <TitleTxt>TRUSTEE</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>DR E RATCLIFFE ANDERSON JR</PersonNm>
        <TitleTxt>TRUSTEE</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>GERRY BYRNE</PersonNm>
        <TitleTxt>TRUSTEE</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>HADLEY FISHER</PersonNm>
        <TitleTxt>TRUSTEE</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>BETSY GOTBAUM</PersonNm>
        <TitleTxt>TRUSTEE</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>DR PAUL GREENGARD</PersonNm>
        <TitleTxt>TRUSTEE</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>JAMES L NEDERLANDER</PersonNm>
        <TitleTxt>TRUSTEE</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>RICHARD J SALEM</PersonNm>
        <TitleTxt>TRUSTEE</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>DR MOSHE SHIKE</PersonNm>
        <TitleTxt>TRUSTEE</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>DAVID HW TURNER</PersonNm>
        <TitleTxt>TRUSTEE</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>LOIS WHITMAN-HESS</PersonNm>
        <TitleTxt>TRUSTEE</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>LUCRETIA HOLDEN</PersonNm>
        <TitleTxt>SENIOR VICE PRESIDENT</TitleTxt>
        <AverageHoursPerWeekRt>40.00</AverageHoursPerWeekRt>
        <HighestCompensatedEmployeeInd>X</HighestCompensatedEmployeeInd>
        <ReportableCompFromOrgAmt>148897</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>10754</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <TotalReportableCompFromOrgAmt>555147</TotalReportableCompFromOrgAmt>
      <TotReportableCompRltdOrgAmt>0</TotReportableCompRltdOrgAmt>
      <TotalOtherCompensationAmt>10754</TotalOtherCompensationAmt>
      <IndivRcvdGreaterThan100KCnt>2</IndivRcvdGreaterThan100KCnt>
      <FormerOfcrEmployeesListedInd>0</FormerOfcrEmployeesListedInd>
      <TotalCompGreaterThan150KInd>1</TotalCompGreaterThan150KInd>
      <CompensationFromOtherSrcsInd>0</CompensationFromOtherSrcsInd>
      <ContractorCompensationGrp>
        <ContractorName>
          <BusinessName>
            <BusinessNameLine1Txt>STAYWELL COMPANY LLC</BusinessNameLine1Txt>
          </BusinessName>
        </ContractorName>
        <ContractorAddress>
          <USAddress>
            <AddressLine1Txt>407 NORWALK STREET</AddressLine1Txt>
            <CityNm>GREENSBORO</CityNm>
            <StateAbbreviationCd>NC</StateAbbreviationCd>
            <ZIPCd>27407</ZIPCd>
          </USAddress>
        </ContractorAddress>
        <ServicesDesc>PYM MAGAZINE PUBLISHER</ServicesDesc>
        <CompensationAmt>185823</CompensationAmt>
      </ContractorCompensationGrp>
      <CntrctRcvdGreaterThan100KCnt>1</CntrctRcvdGreaterThan100KCnt>
      <FederatedCampaignsAmt>276588</FederatedCampaignsAmt>
      <AllOtherContributionsAmt>5088833</AllOtherContributionsAmt>
      <NoncashContributionsAmt>62725</NoncashContributionsAmt>
      <TotalContributionsAmt>5365421</TotalContributionsAmt>
      <InvestmentIncomeGrp>
        <TotalRevenueColumnAmt>324830</TotalRevenueColumnAmt>
        <ExclusionAmt>324830</ExclusionAmt>
      </InvestmentIncomeGrp>
      <GrossAmountSalesAssetsGrp>
        <SecuritiesAmt>9327703</SecuritiesAmt>
      </GrossAmountSalesAssetsGrp>
      <LessCostOthBasisSalesExpnssGrp>
        <SecuritiesAmt>9789423</SecuritiesAmt>
      </LessCostOthBasisSalesExpnssGrp>
      <GainOrLossGrp>
        <SecuritiesAmt>-461720</SecuritiesAmt>
      </GainOrLossGrp>
      <NetGainOrLossInvestmentsGrp>
        <TotalRevenueColumnAmt>-461720</TotalRevenueColumnAmt>
        <ExclusionAmt>-461720</ExclusionAmt>
      </NetGainOrLossInvestmentsGrp>
      <OtherRevenueMiscGrp>
        <Desc>MISCELLANEOUS REVENUE</Desc>
        <BusinessCd>900099</BusinessCd>
        <TotalRevenueColumnAmt>670</TotalRevenueColumnAmt>
        <ExclusionAmt>670</ExclusionAmt>
      </OtherRevenueMiscGrp>
      <OtherRevenueTotalAmt>670</OtherRevenueTotalAmt>
      <TotalRevenueGrp>
        <TotalRevenueColumnAmt>5229201</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>0</RelatedOrExemptFuncIncomeAmt>
        <UnrelatedBusinessRevenueAmt>0</UnrelatedBusinessRevenueAmt>
        <ExclusionAmt>-136220</ExclusionAmt>
      </TotalRevenueGrp>
      <GrantsToDomesticOrgsGrp>
        <TotalAmt>2770707</TotalAmt>
        <ProgramServicesAmt>2770707</ProgramServicesAmt>
      </GrantsToDomesticOrgsGrp>
      <ForeignGrantsGrp>
        <TotalAmt>50000</TotalAmt>
        <ProgramServicesAmt>50000</ProgramServicesAmt>
      </ForeignGrantsGrp>
      <CompCurrentOfcrDirectorsGrp>
        <TotalAmt>387500</TotalAmt>
        <ProgramServicesAmt>290625</ProgramServicesAmt>
        <ManagementAndGeneralAmt>38750</ManagementAndGeneralAmt>
        <FundraisingAmt>58125</FundraisingAmt>
      </CompCurrentOfcrDirectorsGrp>
      <OtherSalariesAndWagesGrp>
        <TotalAmt>615204</TotalAmt>
        <ProgramServicesAmt>361455</ProgramServicesAmt>
        <ManagementAndGeneralAmt>128026</ManagementAndGeneralAmt>
        <FundraisingAmt>125723</FundraisingAmt>
      </OtherSalariesAndWagesGrp>
      <PensionPlanContributionsGrp>
        <TotalAmt>3424</TotalAmt>
        <ProgramServicesAmt>2016</ProgramServicesAmt>
        <ManagementAndGeneralAmt>707</ManagementAndGeneralAmt>
        <FundraisingAmt>701</FundraisingAmt>
      </PensionPlanContributionsGrp>
      <OtherEmployeeBenefitsGrp>
        <TotalAmt>47513</TotalAmt>
        <ProgramServicesAmt>27973</ProgramServicesAmt>
        <ManagementAndGeneralAmt>9810</ManagementAndGeneralAmt>
        <FundraisingAmt>9730</FundraisingAmt>
      </OtherEmployeeBenefitsGrp>
      <PayrollTaxesGrp>
        <TotalAmt>43029</TotalAmt>
        <ProgramServicesAmt>25333</ProgramServicesAmt>
        <ManagementAndGeneralAmt>8884</ManagementAndGeneralAmt>
        <FundraisingAmt>8812</FundraisingAmt>
      </PayrollTaxesGrp>
      <FeesForServicesLegalGrp>
        <TotalAmt>18400</TotalAmt>
        <ManagementAndGeneralAmt>18400</ManagementAndGeneralAmt>
      </FeesForServicesLegalGrp>
      <FeesForServicesAccountingGrp>
        <TotalAmt>25100</TotalAmt>
        <ManagementAndGeneralAmt>25100</ManagementAndGeneralAmt>
      </FeesForServicesAccountingGrp>
      <FeesForSrvcInvstMgmntFeesGrp>
        <TotalAmt>32817</TotalAmt>
        <ManagementAndGeneralAmt>32817</ManagementAndGeneralAmt>
      </FeesForSrvcInvstMgmntFeesGrp>
      <FeesForServicesOtherGrp>
        <TotalAmt>125091</TotalAmt>
        <ProgramServicesAmt>123882</ProgramServicesAmt>
        <ManagementAndGeneralAmt>1209</ManagementAndGeneralAmt>
      </FeesForServicesOtherGrp>
      <AdvertisingGrp>
        <TotalAmt>3601</TotalAmt>
        <FundraisingAmt>3601</FundraisingAmt>
      </AdvertisingGrp>
      <OfficeExpensesGrp>
        <TotalAmt>108442</TotalAmt>
        <ProgramServicesAmt>5000</ProgramServicesAmt>
        <ManagementAndGeneralAmt>38514</ManagementAndGeneralAmt>
        <FundraisingAmt>64928</FundraisingAmt>
      </OfficeExpensesGrp>
      <InformationTechnologyGrp>
        <TotalAmt>43903</TotalAmt>
        <ProgramServicesAmt>40372</ProgramServicesAmt>
        <ManagementAndGeneralAmt>3531</ManagementAndGeneralAmt>
      </InformationTechnologyGrp>
      <TravelGrp>
        <TotalAmt>50137</TotalAmt>
        <ProgramServicesAmt>23457</ProgramServicesAmt>
        <ManagementAndGeneralAmt>24238</ManagementAndGeneralAmt>
        <FundraisingAmt>2442</FundraisingAmt>
      </TravelGrp>
      <ConferencesMeetingsGrp>
        <TotalAmt>387</TotalAmt>
        <ManagementAndGeneralAmt>387</ManagementAndGeneralAmt>
      </ConferencesMeetingsGrp>
      <DepreciationDepletionGrp>
        <TotalAmt>591</TotalAmt>
        <ManagementAndGeneralAmt>591</ManagementAndGeneralAmt>
      </DepreciationDepletionGrp>
      <InsuranceGrp>
        <TotalAmt>9855</TotalAmt>
        <ManagementAndGeneralAmt>9855</ManagementAndGeneralAmt>
      </InsuranceGrp>
      <OtherExpensesGrp>
        <Desc>FILM PROD &amp; TRAVEL COST</Desc>
        <TotalAmt>89064</TotalAmt>
        <ProgramServicesAmt>89064</ProgramServicesAmt>
      </OtherExpensesGrp>
      <OtherExpensesGrp>
        <Desc>RECRUITING</Desc>
        <TotalAmt>11866</TotalAmt>
        <ManagementAndGeneralAmt>11866</ManagementAndGeneralAmt>
      </OtherExpensesGrp>
      <TotalFunctionalExpensesGrp>
        <TotalAmt>4436631</TotalAmt>
        <ProgramServicesAmt>3809884</ProgramServicesAmt>
        <ManagementAndGeneralAmt>352685</ManagementAndGeneralAmt>
        <FundraisingAmt>274062</FundraisingAmt>
      </TotalFunctionalExpensesGrp>
      <CashNonInterestBearingGrp>
        <BOYAmt>2009489</BOYAmt>
        <EOYAmt>2375934</EOYAmt>
      </CashNonInterestBearingGrp>
      <SavingsAndTempCashInvstGrp>
        <BOYAmt>8019273</BOYAmt>
        <EOYAmt>8568653</EOYAmt>
      </SavingsAndTempCashInvstGrp>
      <PledgesAndGrantsReceivableGrp>
        <BOYAmt>1137899</BOYAmt>
        <EOYAmt>755410</EOYAmt>
      </PledgesAndGrantsReceivableGrp>
      <InventoriesForSaleOrUseGrp>
        <EOYAmt>5457</EOYAmt>
      </InventoriesForSaleOrUseGrp>
      <LandBldgEquipCostOrOtherBssAmt>12806</LandBldgEquipCostOrOtherBssAmt>
      <LandBldgEquipAccumDeprecAmt>9095</LandBldgEquipAccumDeprecAmt>
      <LandBldgEquipBasisNetGrp>
        <BOYAmt>932</BOYAmt>
        <EOYAmt>3711</EOYAmt>
      </LandBldgEquipBasisNetGrp>
      <InvestmentsPubTradedSecGrp>
        <BOYAmt>16186323</BOYAmt>
        <EOYAmt>14501122</EOYAmt>
      </InvestmentsPubTradedSecGrp>
      <TotalAssetsGrp>
        <BOYAmt>27353916</BOYAmt>
        <EOYAmt>26210287</EOYAmt>
      </TotalAssetsGrp>
      <AccountsPayableAccrExpnssGrp>
        <BOYAmt>122128</BOYAmt>
        <EOYAmt>171203</EOYAmt>
      </AccountsPayableAccrExpnssGrp>
      <GrantsPayableGrp>
        <BOYAmt>3992654</BOYAmt>
        <EOYAmt>3373361</EOYAmt>
      </GrantsPayableGrp>
      <TotalLiabilitiesGrp>
        <BOYAmt>4114782</BOYAmt>
        <EOYAmt>3544564</EOYAmt>
      </TotalLiabilitiesGrp>
      <OrganizationFollowsSFAS117Ind>X</OrganizationFollowsSFAS117Ind>
      <UnrestrictedNetAssetsGrp>
        <BOYAmt>22839239</BOYAmt>
        <EOYAmt>22284312</EOYAmt>
      </UnrestrictedNetAssetsGrp>
      <TemporarilyRstrNetAssetsGrp>
        <BOYAmt>399895</BOYAmt>
        <EOYAmt>381411</EOYAmt>
      </TemporarilyRstrNetAssetsGrp>
      <TotalNetAssetsFundBalanceGrp>
        <BOYAmt>23239134</BOYAmt>
        <EOYAmt>22665723</EOYAmt>
      </TotalNetAssetsFundBalanceGrp>
      <TotLiabNetAssetsFundBalanceGrp>
        <BOYAmt>27353916</BOYAmt>
        <EOYAmt>26210287</EOYAmt>
      </TotLiabNetAssetsFundBalanceGrp>
      <ReconcilationRevenueExpnssAmt>792570</ReconcilationRevenueExpnssAmt>
      <NetUnrlzdGainsLossesInvstAmt>-1365981</NetUnrlzdGainsLossesInvstAmt>
      <OtherChangesInNetAssetsAmt>0</OtherChangesInNetAssetsAmt>
      <InfoInScheduleOPartXIIInd>X</InfoInScheduleOPartXIIInd>
      <MethodOfAccountingAccrualInd>X</MethodOfAccountingAccrualInd>
      <AccountantCompileOrReviewInd>0</AccountantCompileOrReviewInd>
      <FSAuditedInd>1</FSAuditedInd>
      <FSAuditedBasisGrp>
        <SeparateBasisFinclStmtInd>X</SeparateBasisFinclStmtInd>
      </FSAuditedBasisGrp>
      <AuditCommitteeInd>1</AuditCommitteeInd>
      <FederalGrantAuditRequiredInd>0</FederalGrantAuditRequiredInd>
    </IRS990>
    <IRS990ScheduleA documentId="RetDoc1039100001">
      <PublicOrganization170Ind>X</PublicOrganization170Ind>
      <GiftsGrantsContriRcvd170Grp>
        <CurrentTaxYearMinus4YearsAmt>3213554</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>3248678</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>4377975</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>6064311</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>5365421</CurrentTaxYearAmt>
        <TotalAmt>22269939</TotalAmt>
      </GiftsGrantsContriRcvd170Grp>
      <TotalCalendarYear170Grp>
        <CurrentTaxYearMinus4YearsAmt>3213554</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>3248678</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>4377975</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>6064311</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>5365421</CurrentTaxYearAmt>
        <TotalAmt>22269939</TotalAmt>
      </TotalCalendarYear170Grp>
      <SubstantialContributorsTotAmt>1815402</SubstantialContributorsTotAmt>
      <PublicSupportTotal170Amt>20454537</PublicSupportTotal170Amt>
      <GrossInvestmentIncome170Grp>
        <CurrentTaxYearMinus4YearsAmt>392203</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>491655</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>350202</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>331693</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>324830</CurrentTaxYearAmt>
        <TotalAmt>1890583</TotalAmt>
      </GrossInvestmentIncome170Grp>
      <OtherIncome170Grp>
        <CurrentTaxYearMinus2YearsAmt>1336</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>1790</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>670</CurrentTaxYearAmt>
        <TotalAmt>3796</TotalAmt>
      </OtherIncome170Grp>
      <TotalSupportAmt>24164318</TotalSupportAmt>
      <PublicSupportCY170Pct>0.84650</PublicSupportCY170Pct>
      <PublicSupportPY170Pct>0.81640</PublicSupportPY170Pct>
      <ThirtyThrPctSuprtTestsCY170Ind>X</ThirtyThrPctSuprtTestsCY170Ind>
      <Form990ScheduleAPartVIGrp>
        <FormAndLineReferenceDesc>SCHEDULE A, PART II, LINE 10, EXPLANATION OF OTHER INCOME:</FormAndLineReferenceDesc>
        <ExplanationTxt>MISCELLANEOUS - 2016 AMOUNT: $ 1,336. 2017 AMOUNT: $ 1,790. 2018 AMOUNT: $ 670.</ExplanationTxt>
      </Form990ScheduleAPartVIGrp>
    </IRS990ScheduleA>
    <IRS990ScheduleB documentId="RetDoc1234500001">
      <ContributorInformationGrp>
        <ContributorNum>RESTRICTED</ContributorNum>
        <ContributorBusinessName>
          <BusinessNameLine1>RESTRICTED</BusinessNameLine1>
        </ContributorBusinessName>
        <ContributorUSAddress>
          <AddressLine1>RESTRICTED</AddressLine1>
          <AddressLine2>RESTRICTED</AddressLine2>
          <City>RESTRICTED</City>
          <State>RESTRICTED</State>
          <ZIPCode>RESTRICTED</ZIPCode>
        </ContributorUSAddress>
        <TotalContributionsAmt>RESTRICTED</TotalContributionsAmt>
      </ContributorInformationGrp>
    </IRS990ScheduleB>
    <IRS990ScheduleD documentId="RetDoc1040000001">
      <EquipmentGrp>
        <OtherCostOrOtherBasisAmt>12806</OtherCostOrOtherBasisAmt>
        <DepreciationAmt>9095</DepreciationAmt>
        <BookValueAmt>3711</BookValueAmt>
      </EquipmentGrp>
      <TotalBookValueLandBuildingsAmt>3711</TotalBookValueLandBuildingsAmt>
      <FootnoteTextInd>X</FootnoteTextInd>
      <TotalRevEtcAuditedFinclStmtAmt>4028506</TotalRevEtcAuditedFinclStmtAmt>
      <NetUnrealizedGainsInvstAmt>-1365981</NetUnrealizedGainsInvstAmt>
      <DonatedServicesAndUseFcltsAmt>198103</DonatedServicesAndUseFcltsAmt>
      <RevenueNotReportedAmt>-1167878</RevenueNotReportedAmt>
      <RevenueSubtotalAmt>5196384</RevenueSubtotalAmt>
      <InvestmentExpensesNotIncldAmt>32817</InvestmentExpensesNotIncldAmt>
      <RevenueNotReportedFinclStmtAmt>32817</RevenueNotReportedFinclStmtAmt>
      <TotalRevenuePerForm990Amt>5229201</TotalRevenuePerForm990Amt>
      <TotExpnsEtcAuditedFinclStmtAmt>4601917</TotExpnsEtcAuditedFinclStmtAmt>
      <DonatedServicesUseFcltsAmt>198103</DonatedServicesUseFcltsAmt>
      <ExpensesNotReportedAmt>198103</ExpensesNotReportedAmt>
      <ExpensesSubtotalAmt>4403814</ExpensesSubtotalAmt>
      <InvestmentExpensesNotIncld2Amt>32817</InvestmentExpensesNotIncld2Amt>
      <ExpensesNotRptFinclStmtAmt>32817</ExpensesNotRptFinclStmtAmt>
      <TotalExpensesPerForm990Amt>4436631</TotalExpensesPerForm990Amt>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>PART X, LINE 2:</FormAndLineReferenceDesc>
        <ExplanationTxt>ACCOUNTING FOR UNCERTAINTY IN INCOME TAXES - THE FOUNDATION RECOGNIZES THE EFFECT OF INCOME TAX POSITIONS ONLY IF THOSE POSITIONS ARE MORE LIKELY THAN NOT TO BE SUSTAINED. MANAGEMENT HAS DETERMINED THAT THE FOUNDATION HAD NO UNCERTAIN TAX POSITIONS THAT WOULD REQUIRE FINANCIAL STATEMENT RECOGNITION OR DISCLOSURE. THE FOUNDATION IS NO LONGER SUBJECT TO EXAMINATIONS BY THE APPLICABLE TAXING JURISDICTIONS FOR TAX YEARS PRIOR TO 2015.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleD>
    <IRS990ScheduleF documentId="RetDoc1040500001">
      <GrantRecordsMaintainedInd>1</GrantRecordsMaintainedInd>
      <AccountActivitiesOutsideUSGrp>
        <RegionTxt>EUROPE</RegionTxt>
        <OfficesCnt>0</OfficesCnt>
        <EmployeeCnt>0</EmployeeCnt>
        <TypeOfActivitiesConductedTxt>GRANTS</TypeOfActivitiesConductedTxt>
        <RegionTotalExpendituresAmt>50000</RegionTotalExpendituresAmt>
      </AccountActivitiesOutsideUSGrp>
      <SubtotalOfficesCnt>0</SubtotalOfficesCnt>
      <SubtotalEmployeesCnt>0</SubtotalEmployeesCnt>
      <ContinuationTotalOfficeCnt>0</ContinuationTotalOfficeCnt>
      <ContinuationTotalEmployeeCnt>0</ContinuationTotalEmployeeCnt>
      <TotalOfficeCnt>0</TotalOfficeCnt>
      <TotalEmployeeCnt>0</TotalEmployeeCnt>
      <SubtotalSpentAmt>50000</SubtotalSpentAmt>
      <ContinuationSpentAmt>0</ContinuationSpentAmt>
      <TotalSpentAmt>50000</TotalSpentAmt>
      <GrantsToOrgOutsideUSGrp>
        <RegionTxt>EUROPE</RegionTxt>
        <PurposeOfGrantTxt>RESEARCH</PurposeOfGrantTxt>
        <CashGrantAmt>50000</CashGrantAmt>
        <MannerOfCashDisbursementTxt>WIRE TRANSFER</MannerOfCashDisbursementTxt>
      </GrantsToOrgOutsideUSGrp>
      <Total501c3OrgCnt>1</Total501c3OrgCnt>
      <TotalOtherOrgCnt>0</TotalOtherOrgCnt>
      <TransferToForeignCorpInd>0</TransferToForeignCorpInd>
      <InterestInForeignTrustInd>0</InterestInForeignTrustInd>
      <ForeignCorpOwnershipInd>0</ForeignCorpOwnershipInd>
      <PassiveForeignInvestmestCoInd>0</PassiveForeignInvestmestCoInd>
      <ForeignPartnershipInd>0</ForeignPartnershipInd>
      <BoycottCountriesInd>0</BoycottCountriesInd>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>PART I, LINE 2:</FormAndLineReferenceDesc>
        <ExplanationTxt>RESEARCH WILL BE CARRIED OUT BY THE KAROLINSKA INSTITUTE UNDER THE DIRECTION OF DR. PER SVENNINGSSON TO ELUCIDATE THE MOLECULAR MECHANISMS OF THE ACTION IN THE BRAIN RELATING TO THE CAUSE AND TREATMENT OF NEUROLOGICAL DISORDERS SUCH AS ALZHEIMER'S DISEASE. THE FOUNDATION REQUIRES THE GRANTEE TO SUBMIT AN INTERIM 6-MONTH REPORT ON THE PROGRESS OF THEIR INVESTIGATIONS AS WELL AS A FINAL REPORT UPON COMPLETION OF THE TERM OF THE AGREEMENT.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>PART I, LINE 3:</FormAndLineReferenceDesc>
        <ExplanationTxt>THE ORGANIZATION USES THE ACCRUAL METHOD OF ACCOUNTING TO ACCOUNT FOR ITS FOREIGN EXPENDITURES.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleF>
    <IRS990ScheduleI documentId="RetDoc1041900001">
      <GrantRecordsMaintainedInd>1</GrantRecordsMaintainedInd>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>THE ROCKEFELLER UNIVERSITY</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>1230 YORK AVENUE</AddressLine1Txt>
          <CityNm>NEW YORK</CityNm>
          <StateAbbreviationCd>NY</StateAbbreviationCd>
          <ZIPCd>10021</ZIPCd>
        </USAddress>
        <RecipientEIN>131624158</RecipientEIN>
        <IRCSectionDesc>501(C)(3)</IRCSectionDesc>
        <CashGrantAmt>2595707</CashGrantAmt>
        <PurposeOfGrantTxt>SEE PART IV</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>NYU MEDICAL CENTER</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>550 FIRST AVENUE</AddressLine1Txt>
          <CityNm>NEW YORK</CityNm>
          <StateAbbreviationCd>NY</StateAbbreviationCd>
          <ZIPCd>10016</ZIPCd>
        </USAddress>
        <RecipientEIN>135562308</RecipientEIN>
        <IRCSectionDesc>501(C)(3)</IRCSectionDesc>
        <CashGrantAmt>125000</CashGrantAmt>
        <PurposeOfGrantTxt>SEE PART IV</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>WEIZMANN INSTITUTE OF SCIENCE</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>633 3RD AVENUE 20TH FL</AddressLine1Txt>
          <CityNm>NEW YORK</CityNm>
          <StateAbbreviationCd>NY</StateAbbreviationCd>
          <ZIPCd>10017</ZIPCd>
        </USAddress>
        <RecipientEIN>131623886</RecipientEIN>
        <IRCSectionDesc>501(C)(3)</IRCSectionDesc>
        <CashGrantAmt>50000</CashGrantAmt>
        <PurposeOfGrantTxt>SEE PART IV</PurposeOfGrantTxt>
      </RecipientTable>
      <Total501c3OrgCnt>3</Total501c3OrgCnt>
      <TotalOtherOrgCnt>0</TotalOtherOrgCnt>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>PART I, LINE 2:</FormAndLineReferenceDesc>
        <ExplanationTxt>THE FOUNDATION MONITORS THE USE OF GRANT FUNDS IN THE US BY RECEIVING PERIODIC PROGRESS REPORTS ON THE RESEARCH CONDUCTED AND ANY FINDINGS PUBLISHED AS A RESULT OF THIS FUNDING. THE FISHER CENTER FOR ALZHEIMER'S DISEASE RESEARCH AT THE ROCKEFELLER UNIVERSITY SUBMITS A REPORT AT EACH GENERAL BOARD MEETING WHICH IS INCORPORATED INTO THE MINUTES OF THE MEETING. THE FISHER EDUCATIONAL AND RESOURCES PROGRAM AT NYU SCHOOL OF MEDICINE REPORTS AT THE END OF THE FUNDING PERIOD IN THEIR REQUEST FOR FURTHER FUNDING ON THE PROGRESS TO DATE OF THE RESEARCH ACTIVITIES SUPPORTED BY THE FOUNDATION. THE FOUNDATION FUNDING DECISIONS ARE MADE UNDER THE SOLE AND ABSOLUTE DISCRETION OF THE BOARD PURSUANT TO A MAJORITY VOTE. A SCIENCE ADVISORY BOARD COMPRISED OF MEDICAL AND SCIENTIFIC EXPERTS IN THE FIELD OF ALZHEIMER'S DISEASE AND RELATED DISEASES ADVISES AND ASSISTS THE FOUNDATION IN CONNECTION WITH FUNDING GRANT REQUESTS.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, SCHEDULE I, PART II, COLUMN (H):</FormAndLineReferenceDesc>
        <ExplanationTxt>PURPOSE OF GRANT THE ROCKEFELLER UNIVERSITY: GRANTS TO THE FISHER CENTER FOR ALZHEIMER'S DISEASE RESEARCH AT THE ROCKEFELLER UNIVERSITY FOR NEUROLOGICAL RESEARCH INTO THE CAUSES OF ALZHEIMER'S AND POTENTIAL NEW PHARMACOLOGICAL TREATMENT OPTIONS AND TO SUPPORT PROFESSORSHIP TO CONDUCT RESEARCH ACTIVITIES. NYU MEDICAL CENTER: NYU GRANT TO FISHER EDUCATION AND RESOURCES PROGRAM AT NY UNIVERSITY SCHOOL OF MEDICINE FOR CLINICAL RESEARCH INTO THE EFFICACY OF MEMANTINE AND COMPREHENSIVE INDIVIDUALIZED PATIENT-CENTERED MANAGEMENT OF ALZHEIMER'S DISEASE. WEIZMANN INSTITUTE OF SCIENCE: GRANT TO THE WEIZMANN INSTITUTE OF SCIENCE FOR PROFESSOR MICHAL SCHWARTZ AND HER TEAM TO PERFORM RESEARCH ON THE CAUSE AND TREATMENT OF ALZHEIMER'S DISEASE.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleI>
    <IRS990ScheduleJ documentId="RetDoc1042400001">
      <CompensationCommitteeInd>X</CompensationCommitteeInd>
      <Form990OfOtherOrganizationsInd>X</Form990OfOtherOrganizationsInd>
      <CompensationSurveyInd>X</CompensationSurveyInd>
      <BoardOrCommitteeApprovalInd>X</BoardOrCommitteeApprovalInd>
      <SeverancePaymentInd>0</SeverancePaymentInd>
      <SupplementalNonqualRtrPlanInd>0</SupplementalNonqualRtrPlanInd>
      <EquityBasedCompArrngmInd>0</EquityBasedCompArrngmInd>
      <CompBasedOnRevenueOfFlngOrgInd>0</CompBasedOnRevenueOfFlngOrgInd>
      <CompBsdOnRevRelatedOrgsInd>0</CompBsdOnRevRelatedOrgsInd>
      <CompBsdNetEarnsFlngOrgInd>0</CompBsdNetEarnsFlngOrgInd>
      <CompBsdNetEarnsRltdOrgsInd>0</CompBsdNetEarnsRltdOrgsInd>
      <AnyNonFixedPaymentsInd>1</AnyNonFixedPaymentsInd>
      <InitialContractExceptionInd>0</InitialContractExceptionInd>
      <RltdOrgOfficerTrstKeyEmplGrp>
        <PersonNm>KENT KAROSEN</PersonNm>
        <TitleTxt>PRESIDENT/CEO (THRU NOV. 2018)</TitleTxt>
        <BaseCompensationFilingOrgAmt>250000</BaseCompensationFilingOrgAmt>
        <CompensationBasedOnRltdOrgsAmt>0</CompensationBasedOnRltdOrgsAmt>
        <BonusFilingOrganizationAmount>137500</BonusFilingOrganizationAmount>
        <BonusRelatedOrganizationsAmt>0</BonusRelatedOrganizationsAmt>
        <OtherCompensationFilingOrgAmt>18750</OtherCompensationFilingOrgAmt>
        <OtherCompensationRltdOrgsAmt>0</OtherCompensationRltdOrgsAmt>
        <DeferredCompensationFlngOrgAmt>0</DeferredCompensationFlngOrgAmt>
        <DeferredCompRltdOrgsAmt>0</DeferredCompRltdOrgsAmt>
        <NontaxableBenefitsFilingOrgAmt>0</NontaxableBenefitsFilingOrgAmt>
        <NontaxableBenefitsRltdOrgsAmt>0</NontaxableBenefitsRltdOrgsAmt>
        <TotalCompensationFilingOrgAmt>406250</TotalCompensationFilingOrgAmt>
        <TotalCompensationRltdOrgsAmt>0</TotalCompensationRltdOrgsAmt>
        <CompReportPrior990FilingOrgAmt>0</CompReportPrior990FilingOrgAmt>
        <CompReportPrior990RltdOrgsAmt>0</CompReportPrior990RltdOrgsAmt>
      </RltdOrgOfficerTrstKeyEmplGrp>
      <RltdOrgOfficerTrstKeyEmplGrp>
        <PersonNm>LUCRETIA HOLDEN</PersonNm>
        <TitleTxt>SENIOR VICE PRESIDENT</TitleTxt>
        <BaseCompensationFilingOrgAmt>134897</BaseCompensationFilingOrgAmt>
        <CompensationBasedOnRltdOrgsAmt>0</CompensationBasedOnRltdOrgsAmt>
        <BonusFilingOrganizationAmount>14000</BonusFilingOrganizationAmount>
        <BonusRelatedOrganizationsAmt>0</BonusRelatedOrganizationsAmt>
        <OtherCompensationFilingOrgAmt>0</OtherCompensationFilingOrgAmt>
        <OtherCompensationRltdOrgsAmt>0</OtherCompensationRltdOrgsAmt>
        <DeferredCompensationFlngOrgAmt>0</DeferredCompensationFlngOrgAmt>
        <DeferredCompRltdOrgsAmt>0</DeferredCompRltdOrgsAmt>
        <NontaxableBenefitsFilingOrgAmt>10754</NontaxableBenefitsFilingOrgAmt>
        <NontaxableBenefitsRltdOrgsAmt>0</NontaxableBenefitsRltdOrgsAmt>
        <TotalCompensationFilingOrgAmt>159651</TotalCompensationFilingOrgAmt>
        <TotalCompensationRltdOrgsAmt>0</TotalCompensationRltdOrgsAmt>
        <CompReportPrior990FilingOrgAmt>0</CompReportPrior990FilingOrgAmt>
        <CompReportPrior990RltdOrgsAmt>0</CompReportPrior990RltdOrgsAmt>
      </RltdOrgOfficerTrstKeyEmplGrp>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>PART I, LINE 7</FormAndLineReferenceDesc>
        <ExplanationTxt>IN RECOGNITION OF THEIR ACHIEVEMENT IN ELEVATING AND EXPANDING THE VISION AND MISSION OF THE FOUNDATION'S INITIATIVES, PRESIDENT/CEO KENT L. KAROSEN WAS AWARDED A BONUS FOR 2017 IN THE AMOUNT OF $62,500 AND A SECOND BONUS FOR 2018 THE AMOUNT OF $75,000; BOTH WERE PAID IN 2018. THE SENIOR VICE PRESIDENT LUCRETIA HOLDEN WAS AWARDED A BONUS OF $14,000. THE BONUSES WERE PROVIDED AT THE DISCRETION OF THE BOARD'S COMPENSATION COMMITTEE BY A UNANIMOUS VOTE.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleJ>
    <IRS990ScheduleL documentId="RetDoc1042800001">
      <BusTrInvolveInterestedPrsnGrp>
        <NameOfInterested>
          <BusinessName>
            <BusinessNameLine1Txt>CENTURY BANK</BusinessNameLine1Txt>
          </BusinessName>
        </NameOfInterested>
        <RelationshipDescriptionTxt>SEE PART V</RelationshipDescriptionTxt>
        <TransactionAmt>6985275</TransactionAmt>
        <TransactionDesc>SEE PART V</TransactionDesc>
        <SharingOfRevenuesInd>0</SharingOfRevenuesInd>
      </BusTrInvolveInterestedPrsnGrp>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, SCHEDULE L, PART IV</FormAndLineReferenceDesc>
        <ExplanationTxt>RESULTING FROM HIGHLY COMPETITIVE RATES OFFERED BY CENTURY BANK, THE FOUNDATION HOLDS $6,985,275 IN CERTIFICATES OF DEPOSIT WITH CENTURY BANK, WHERE MR. BARRY SLOANE (THE FOUNDATION'S CHAIRMAN/TREASURER) SERVES AS PRESIDENT AND CEO. MR. BARRY SLOANE AND HIS FAMILY MEMBERS OWN MORE THAN 35% OF THE TOTAL COMBINED VOTING POWER OF THE CENTURY BANK. THE ENTIRE BOARD WAS MADE AWARE OF THE CONFLICT WITH MR. SLOANE BEFORE THE CD INVESTMENTS WERE MADE AS WELL AS A CONTINUING DISCLOSURE AT ALL SUBSEQUENT BOARD MEETINGS. THE BOARD UNANIMOUSLY VOTED TO APPROVE THE INVESTMENTS. MR. SLOANE RECUSED HIMSELF FROM THE VOTE.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleL>
    <IRS990ScheduleM documentId="RetDoc1042900001">
      <SecuritiesPubliclyTradedGrp>
        <NonCashCheckboxInd>X</NonCashCheckboxInd>
        <ContributionCnt>12</ContributionCnt>
        <NoncashContributionsRptF990Amt>62725</NoncashContributionsRptF990Amt>
        <MethodOfDeterminingRevenuesTxt>AVG SELLING PRICE</MethodOfDeterminingRevenuesTxt>
      </SecuritiesPubliclyTradedGrp>
      <Form8283ReceivedCnt>0</Form8283ReceivedCnt>
      <AnyPropertyThatMustBeHeldInd>0</AnyPropertyThatMustBeHeldInd>
      <ReviewProcessUnusualNCGiftsInd>0</ReviewProcessUnusualNCGiftsInd>
      <ThirdPartiesUsedInd>0</ThirdPartiesUsedInd>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>PART I, COLUMN (B):</FormAndLineReferenceDesc>
        <ExplanationTxt>THE ORGANIZATION IS REPORTING THE NUMBER OF DONORS ON PART I, LINE 9, COLUMN (B).</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleM>
    <IRS990ScheduleO documentId="RetDoc1044400001">
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART I, LINE 1</FormAndLineReferenceDesc>
        <ExplanationTxt>THE FOUNDATION'S FUNDING AND ACTIVITIES ARE DIRECTED TOWARDS THE CAUSE, CARE &amp; CURE OF ALZHEIMER'S DISEASE. THE FOUNDATION FUNDS RESEARCH INTO THE CAUSE AND CURE OF ALZHEIMER'S DISEASE AT THE FISHER CTR FOR ALZHEIMER'S DISEASE RESEARCH AT THE ROCKEFELLER UNIV., UNDER THE DIRECTION OF NOBEL LAUREATE DR. PAUL GREENGARD,WHOSE FINDINGS HAVE BEEN THE BASIS FOR MUCH OF TODAY'S ALZHEIMER'S INVESTIGATIONS. IT ALSO FUNDS PROJECTS FOR THE CARE OF PEOPLE WITH ALZHEIMER'S DISEASE AND THEIR CAREGIVERS AT THE FISHER ALZHEIMER'S DISEASE EDUCATION AND RESOURCES PROGRAM AT THE NEW YORK UNIVERSITY SCHOOL OF MEDICINE, UNDER THE DIRECTION OF BARRY REISBERG,MD., PROVIDING NON-PHARMACOLOGICAL TREATMENT OPTIONS TO IMPROVE CARE OF PEOPLE WITH ALZHEIMER'S. THE FOUNDATION PROVIDES EDUCATION &amp; INFORMATION TO THE PUBLIC THROUGH ITS WEBSITE WWW.ALZINFO.ORG, ITS PERIODIC MAGAZINE,PRESERVING YOUR MEMORY, AND A BI-WEEKLY E-NEWSLETTER OF THE LATEST EXPERT-REVIEWED RESEARCH FINDINGS ON CARE AND POSSIBLE TREATMENTS FOR ALZHEIMER'S.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART VI, SECTION A, LINE 2</FormAndLineReferenceDesc>
        <ExplanationTxt>KENT KAROSEN WAS A PARTNER AND EMPLOYEE OF CANTOR FITZGERALD, L.P. AND HE AND HIS ENTITIES, INCLUDING KAROSEN STRATEGIC PARTNERS, HAVE PROVIDED CONSULTING AND OTHER SERVICES FROM TIME TO TIME FOR HOWARD W. LUTNICK AND THE CANTOR ENTITIES. MR. LUTNICK ALSO SERVES AS TRUSTEE FOR CERTAIN OF MR. KAROSEN'S TRUSTS.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART VI, SECTION B, LINE 11B</FormAndLineReferenceDesc>
        <ExplanationTxt>THE 990 IS INITIALLY REVIEWED BY MEMBERS OF THE AUDIT COMMITTEE THAT CONSISTS OF 3 INDEPENDENT TRUSTEES. A COPY OF THE 990 IS THEN FORWARDED ELECTRONICALLY VIA EMAIL TO ALL BOARD MEMBERS AND RELEVANT MANAGEMENT PERSONNEL FOR THEIR REVIEW AND COMMENT BEFORE THE 990 IS FILED. IF ANY REVISIONS ARE REQUIRED, THEY ARE MADE AND THE REVISED 990 IS RESUBMITTED TO ALL BOARD MEMBERS FOR FINAL REVIEW BEFORE FILING.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART VI, SECTION B, LINE 12C</FormAndLineReferenceDesc>
        <ExplanationTxt>THE FOUNDATION HAS A CONFLICT OF INTEREST POLICY WHICH IS ANNUALLY MONITORED REQUIRING ALL TRUSTEES TO DISCLOSE ANY POSSIBLE CONFLICT OF INTEREST VIA EMAIL RESPONSE TO THE SENIOR VICE PRESIDENT. THE FOUNDATION REQUIRES THAT ALL TRUSTEES, OFFICERS, KEY EMPLOYEES AND STAFF PERSONNEL PROMPTLY AND FULLY DISCLOSE ALL MATERIAL FACTS OF ANY ACTUAL OR POTENTIAL CONFLICT OF INTEREST THAT MAY EXIST AT THE TIME THE TRUSTEE IS APPOINTED OR STAFF PERSONNEL IS HIRED, OR AS THEY MAY ARISE WHILE THE TRUSTEE IS SERVING ON THE BOARD OR THE STAFF PERSONNEL IS EMPLOYED BY THE FOUNDATION. SUCH DISCLOSURES INVOLVING A TRANSACTION, ARRANGEMENT OR DECISION BEING CONSIDERED BY THE BOARD ARE MADE KNOWN TO ALL TRUSTEES. THE BOARD THEN DETERMINES WHETHER A CONFLICT OF INTEREST EXISTS WITH THE INTERESTED PARTY ABSTAINING FROM THE DECISION. IF IT IS DETERMINED THAT NO CONFLICT EXISTS, THEN THE BOARD VOTES ON THE TRANSACTION BUT WITH THE INTERESTED PARTY RECUSING HIMSELF FROM THE DISCUSSION AND VOTE ON SAID MATTER.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART VI, SECTION B, LINE 15A</FormAndLineReferenceDesc>
        <ExplanationTxt>THE FOUNDATION HAS A COMPENSATION COMMITTEE CONSISTING OF 4 INDEPENDENT TRUSTEES TO DETERMINE THE COMPENSATION OF THE PRESIDENT/CEO, SENIOR VICE PRESIDENT AND TOP MANAGEMENT AND KEY EMPLOYEES AT LEAST ONCE A YEAR.THE COMMITTEE IS MANDATED BY ITS CHARTER TO REVIEW EXECUTIVE AND OTHER KEY EMPLOYEE PERFORMANCE CONSISTENT WITH THE GOALS AND OBJECTIVES OF THE FOUNDATION AS DETERMINED BY THE BOARD OF TRUSTEES AND TO DETERMINE AN APPROPRIATE LEVEL OF COMPENSATION IN LIGHT OF THIS PERFORMANCE REVIEW AND USING OTHER SUBSTANTIATING DATA SURVEYS ON CURRENT COMPENSATION RATES FOR SIMILAR POSITIONS IN OTHER COMPARABLE NONPROFITS IN THE NEW YORK CITY AREA.THE COMMITTEE'S DECISION IS DOCUMENTED IN A CONTEMPORANEOUSLY WRITTEN FORMAT (COMPENSATION COMMITTEE MINUTES) INDICATING THE DATE OF THE MEETING, THE MEMBERS PRESENT, AND THE COMPARABLE DATA USED TO MAKE THE DECISION.THE COMPENSATION REVIEW PROCESS FOR THE PRESIDENT/CEO AND EXECUTIVE VICE PRESIDENT WAS LAST UNDERTAKEN IN DECEMBER 2018.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART VI, SECTION C, LINE 19</FormAndLineReferenceDesc>
        <ExplanationTxt>THE FOUNDATION MAKES ITS FORM 990 AND AUDITED FINANCIAL STATEMENTS AVAILABLE FOR PUBLIC INSPECTION AS REQUIRED UNDER SECTION 6104 OF THE INTERNAL REVENUE CODE BY POSTING IT ON THEIR WEBSITE AS WELL AS OTHER SIMILAR WEBSITES SUCH AS WWW.GUIDESTAR.ORG. IN ADDITION, THE FORM 990 AND AUDITED FINANCIAL STATEMENTS, CONFLICT OF INTEREST POLICY AND OTHER POLICIES ARE AVAILABLE UPON WRITTEN REQUEST AT 110 E. 42ND STREET, FL 16, NEW YORK, NY 10017 OR BY CALLING THE ORGANIZATION DIRECTLY AT (800) 259-4636 OR (212) 915-1321.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART XII, LINE 2C:</FormAndLineReferenceDesc>
        <ExplanationTxt>THE FOUNDATION HAS AN AUDIT COMMITTEE THAT IS RESPONSIBLE FOR OVERSIGHT OF THE AUDIT AND ITS FINANCIAL STATEMENTS AND SELECTION OF AN INDEPENDENT ACCOUNTANT. THE PROCESS HAS NOT CHANGED FROM THE PREVIOUS YEAR.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleO>
  </ReturnData>
</Return>